Effect of neoadjuvant chemotherapy (NAC) on programmed cell death ligand (PD-L1) in patients of carcinoma breast: A prospective study in Indian tertiary care setting
Context: Several studies have reported that PD-L1 has shown therapeutic activity in various tumor types. However, its expression changes in a person on administration of NAC which is reported by very few studies. Aims: To find out the difference in the expression of PD-L1 by tumor cells after the ad...
Main Authors: | Vipul Srivastava, B R Akshay, Sweety Kumari, Ram Niwas Meena, Rahul Khanna |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Subjects: | |
Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2020;volume=9;issue=8;spage=4086;epage=4091;aulast=Srivastava |
Similar Items
-
Neoadjuvant and Adjuvant Chemotherapy for Pancreatic Adenocarcinoma: Literature Review and Our Experience of NAC-GS
by: Taku Aoki, et al.
Published: (2024-02-01) -
Lymph Node Ratio (LNR): Predicting Prognosis after Neoadjuvant Chemotherapy (NAC) in Breast Cancer Patients
by: Atilla Soran, et al.
Published: (2019-10-01) -
Tumor cell PD-L1 predicts poor local control for rectal cancer patients following neoadjuvant radiotherapy
by: Shao LD, et al.
Published: (2017-06-01) -
Navigating the microbial community in the trachea-oropharynx of breast cancer patients with or without neoadjuvant chemotherapy (NAC) via endotracheal tube: has NAC caused any change?
by: Hee Yeon Kim, et al.
Published: (2023-11-01) -
Low-Coordinate Mixed Ligand NacNac Complexes of Rare Earth Metals
by: Svetlana V. Klementyeva, et al.
Published: (2023-02-01)